Jaime Contreras, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,142 shares at $44.64 ($51K) on 2017-03-31, disclosed to the SEC on 2017-04-04.
Scheduled sale ($51k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.55 | 375 | $17K | 32.8% |
| 2 | $44.64 | 767 | $34K | 67.2% |
| Total | $44.61 avg | 1,142 | $51K | 100% |
| Filing → |
| ABT | SELL | 2019-04-24 | $134K | — | Filing → |
| ABT | SELL | 2019-03-04 | $1.9M | — | Filing → |
| ABT | SELL | 2019-02-01 | $12.4M | — | Filing → |